🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are happy to share that we have launched a collaborative trial (PRECISE-HI) with UW Medicine and Fred Hutch Cancer Center to use Foresight CLARITY LDT diagnostic to reduce chemo exposure for cHL patients who show early response to treatment. Read more: [Link to PR on website] #MRD #ctDNA

Foresight Diagnostics is built on the strength of our team. We’re proud of our work to develop diagnostic solutions that revolutionize medical treatment. If you’re interested in joining our awesome team, check out our available roles: foresight-dx.com/careers/

#ICYMI: Our webinar with David Kurtz, Chief Medical Officer of Foresight Diagnostics, on the latest advancements in minimal residual disease (#MRD) detection and monitoring in early-stage #lungcancer and #breastcancer, is now available to view here: bit.ly/43iJ4wa

Thank you GenomeWeb for the opportunity to emphasize the importance of the NCCN’s decision to recommend #ctDNA #MRD testing for #DLBCL. Learn more about the impact on DLBCL standard of care and our plans to meaningfully transform patient outcomes: bit.ly/4hm4AU5

We are looking forward to attending #IUCLS2025. Interested in learning more about Foresight CLARITY ultra-sensitive #MRD for lymphoma? Contact us to arrange a meeting: lnkd.in/etNExaqs #ctDNA #PrecisionMedicine #Oncology #CancerResearch #Lymphoma

This #WorldHealthDay, we believe in empowering patients to take control of their health journey. Foresight CLARITY™ helps detect relapse earlier for those with residual disease and will eventually enable clinicians to make more personalized treatment decisions for their patients

We are looking forward to attending #AACR25. Interested in learning more about our Foresight CLARITY™ ultra-sensitive #MRD for lymphoma and solid tumors? Contact us to arrange a meeting: lnkd.in/etNExaqs #ctDNA #PrecisionMedicine #Oncology #CancerResearch #Lymphoma

Our very own CMO and co-founder, David Kurtz, was featured on the #ASCODailyNews discussing the incorporation of #ctDNA-MRD in NCCN Guidelines for B-cell Lymphoma. Read the article here: bit.ly/4jCKiHm #PrecisionMedicine #ctDNA #Diagnostics #MRD ASCO

We are pleased to have the opportunity to share both an oral and poster presentation of new data in newly diagnosed #DLBCL at #ASCO25. Stop by our booth, IH #3, to see how we are powering precision for improved clinical trials. Read more: bit.ly/4jBgdII

We are excited to share that our CEO, Jake Chabon, will attend the Jefferies Global Healthcare Conference on June 3-4, 2025, in New York City. He will be available for 1x1 meetings on both days. To schedule a meeting: bit.ly/4jIyl3j #MRD #ctDNA #PrecisionMedicine

For #CTD25 and #NCRM25 we want to highlight our commitment to improving outcomes for patients and bring awareness to MRD- driven clinical trials! More about our current partnerships here: t.ly/DJmYh

Don’t forget to attend our oral and poster presentations of new data in newly diagnosed #DLBCL at #ASCO25. Stop by our booth, IH #3, to see how we are powering precision for improved clinical trials. Read more: bit.ly/4k6grrg

We are happy to announce that we’ve begun a strategic partnership with QIAGEN to advance development of companion diagnostic kits for #Lymphoma. More information about the partnership here: bit.ly/3FCupSP #ctDNA #MRD #cancer

Every team at Foresight contributed to a successful #ASCO25 and for the patients that are waiting for us to deliver. We look forward to seeing everyone next year! View our oral presentation here: bit.ly/43LAvbs View our poster here: bit.ly/4jzS2cH

We are pleased to share that we will present at #EHA2025 and #18ICML an encore of the prognostic value of Foresight CLARITYTM MRD detection in #DLBCL. Additionally, we will present a poster on behalf of our partner, Kite, a Gilead Company. Read more: bit.ly/4n0f8MI

Our team is looking forward to meeting with partners at #BIO2025, June 16-19 in Boston! Interested in learning more about Foresight CLARITY™ MRD detection for lymphoma and solid tumors? Contact us for a meeting: lnkd.in/eXurmSst #MRD #ctDNA #PrecisionMedicine #Oncology

On #NationalCancerSurvivorMonth, we honor the strength, resilience and courage of all cancer #survivors and their families. We look forward to helping clinicians detect #relapse more quickly so patients can get the treatment they need to beat cancer and #survive.

Our VP of Medical Affairs will participate in a panel titled “Defining Endpoints & MRD Strategies to Advance Precision Oncology Trials” at the Liquid Biopsy for Precision Oncology Summit in Boston! #MRD #ctDNA #CancerDiagnostics #PrecisionMedicine #LiquidBiopsy #ClinicalTrials

This Independence Day, we celebrate freedom, resilience, and the pursuit of better health. We’re committed to advancing #cancer detection through #MRD testing — because independence in health matters. #IndependenceDay #FourthOfJuly #PrecisionMedicine #Oncology #MRD

Dr. Jeremy Abramson (Mass General/Harvard) spotlighted Foresight CLARITY #MRD detection in a prospective, real-world cohort presented at #ASCO2025. At Foresight, we’re proud to back tools driving smarter interventions and personalized treatment: bit.ly/4kb7o7D